findmyKOL

Nerses Sanossian, MD

Enriched profile

Professor of Neurology (Clinical Scholar) (Part-Time), Keck School of Medicine of USC · Keck School of Medicine of USC

ORCID↗NPI↗
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyNeurocritical CareFocusAcute Ischemic Stroke Management+4
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceverified 2026Payments2021–2024NIH fundingNone on fileWhy? →

Nerses Sanossian is Professor of Neurology (Clinical Scholar) (Part-Time), Keck School of Medicine of USC at Keck School of Medicine of USC. OpenAlex indexes 375 publications with 8,981 citations (h-index 48); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 12 Oct 2026

Nerses Sanossian, MD, is Professor of Neurology (Clinical Scholar) (Part-Time), Keck School of Medicine of USC. The public record shows 375 publications with 8,981 citations (h-index 48), centered on Acute Ischemic Stroke Management, Intracerebral and Subarachnoid Hemorrhage Research, Intracranial Aneurysms: Treatment and Complications. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 5 companies.

  • Most recent indexed publication: 2024 · Journal of the American Heart Association
  • Top research focus: Acute Ischemic Stroke Management
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 5 companies

Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Stroke1 trial

Research focus

OpenAlex concept fingerprint
Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage ResearchIntracranial Aneurysms: Treatment and ComplicationsCerebrovascular and Carotid Artery DiseasesEmergency and Acute Care Studies

Drugs & molecules

across trials, industry payments and publications
Andexxageneric · Andexanet alfaClinical trials—Industry payments31Publications—Tnkasegeneric · TenecteplaseClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments16AstraZeneca Pharmaceuticals LPClinical trials—Industry payments15Silk Road Medical, Inc.Clinical trials—Industry payments5

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
375publications

Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.

8,981citations

Total citations across indexed works.

48h-index

Hirsch index (OpenAlex). i10-index 119.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
5companies · 2021–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 12 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 12 Oct 2026

5 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 12 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 12 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jeffrey L. Saver200David S. Liebeskind189Sidney J. Starkman143

Online presence

Updated 12 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/nerses-sanossian-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/USC_Stroke/status/1102734299059478529

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 12 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution
  • Medical Director of Stroke Centers

    Los Angeles General Medical Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.sc-ctsi.org ↗
  • Medical Director of Stroke Centers

    USC Verdugo Hills Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.sc-ctsi.org ↗
  • Director

    Roxanna Todd Hodges Stroke Program at USC; Medical Director, Roxana Todd Hodges Comprehensive Stroke Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.sc-ctsi.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.